SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-014712
Filing Date
2020-08-05
Accepted
2020-08-05 15:32:17
Documents
57
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 666780
2 ex3.htm EX-3 24768
3 ex31-1.htm EX-31.1 12444
4 ex31-2.htm EX-31.2 12495
5 ex32-1.htm EX-32.1 12428
  Complete submission text file 0001493152-20-014712.txt   2716249

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE pcsa-20200630.xml EX-101.INS 275059
7 XBRL SCHEMA FILE pcsa-20200630.xsd EX-101.SCH 51773
8 XBRL CALCULATION FILE pcsa-20200630_cal.xml EX-101.CAL 45930
9 XBRL DEFINITION FILE pcsa-20200630_def.xml EX-101.DEF 108492
10 XBRL LABEL FILE pcsa-20200630_lab.xml EX-101.LAB 260882
11 XBRL PRESENTATION FILE pcsa-20200630_pre.xml EX-101.PRE 179164
Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Filer) CIK: 0001533743 (see all company filings)

IRS No.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-184948 | Film No.: 201076958
SIC: 2834 Pharmaceutical Preparations